February 6, 2025 09:48 AM ESTUpdated 10:00 AM
People
Pharma

Pfiz­er hires No­var­tis on­col­o­gy ex­ec to steer its can­cer am­bi­tions

Kyle LaHucik

Senior Reporter

Af­ter pro­mot­ing its on­col­o­gy of­fi­cer Chris Boshoff to chief sci­en­tif­ic of­fi­cer last fall, Pfiz­er has found his suc­ces­sor.

Jeff Le­gos, the glob­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bris­tol My­ers launch­es fresh round of ma­jor cost cuts in bid to get ahead of patent cliff

As­traZeneca takes $753M charge on aban­doned com­ple­ment drug from Alex­ion deal

Up­dat­ed: Lil­ly posts 45% sales jump, culls four pro­grams across obe­si­ty, Alzheimer's, heart fail­ure and eczema

As­traZeneca of­fers some de­tail on Chi­na probe, reaf­firms com­mit­ment to that mar­ket

J&J, In­tra-Cel­lu­lar quick­ly sealed $14B deal as three oth­ers passed on buy­ing the neu­ro drug­mak­er

No­vo Nordisk is feel­ing the com­pe­ti­tion from com­pound­ed GLP-1s, ex­ec says

A service from the Financial Times